[PTX] YoY Quarter Result on 31-Dec-2019 [#Q2]

Stock
[PTX] Prescient Therapeutics Limited
Announcement Date
30-Dec-2019
Financial Year
2020
Quarter
31-Dec-2019 [#Q2]
Profit Trend
QoQ- 22.97%
YoY- -6.46%
Quarter Report
PTX's Result
PTX's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 1,255 842 648 599 711 457 563 14.28%
PBT -4,084 -3,428 -2,396 -2,296 -1,594 -1,180 -1,024 25.91%
Tax -1,205 -812 -598 -599 0 0 0 -
NP -2,880 -2,616 -1,798 -1,697 -1,594 -1,180 -1,024 18.79%
Tax Rate - - - - - - - -
Total Cost 4,134 3,458 2,446 2,296 2,305 1,637 1,588 17.27%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -229.53 -310.50 -277.59 -283.28 -224.38 -258.42 -181.76 3.96%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.00 -0.00 -0.00 -0.00 -0.01 -0.01 -0.00 -
EPS Diluted -0.00 -0.00 -0.00 -0.00 -0.01 -0.01 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.